数字治疗市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPHC00002236
  • Category : Healthcare IT
  • Status : Published
  • No. of Pages : 181
Buy Now

[研究报告]2021年数字治疗市场规模为42.2694亿美元,预计到2028年将达到180.6179亿美元;预计 2022 年至 2028 年复合年增长率为 23.1%。

分析师观点

市场可能由以下因素推动:智能手机在发达国家和新兴国家的普及率不断上升,数字医疗技术对提供者和患者的成本效益,以及对综合医疗保健系统和以患者为中心的治疗的需求不断增长。据Kepios预测,到2021年4月,全球互联网用户将达到42.7亿,占全球人口的60%以上。随着这个数字的增加,人们对智能健康跟踪的认识预计会提高。发达经济体的消费者越来越意识到用于治疗疾病的创新医疗产品。根据经济合作与发展组织的数据,随着一些经合组织国家的经济状况恶化和医疗支出增加,2020年医疗保健支出占GDP的比例大幅攀升。因此,人们的偏好已转向先进的医疗服务,包括对先进治疗设备的需求增加。产品接受度是推动市场扩张的另一个方面。

市场概述

数字疗法为专注于治疗的患者提供基于证据的治疗侵入。通过程序控制疾病,并使用高质量的软件进行管理。数字疗法在过去几年中取得了进展,利用技术补充或可能取代传统的临床疗法。它们可以独立使用,也可以与设备、药物或其他疗法配合使用,以优化患者护理和健康结果。促进数字治疗市场增长的关键因素是慢性病患病率上升、对慢性病的担忧需要降低医疗保健成本以及公司之间的伙伴关系和协作。然而,网络威胁和数据安全的提高阻碍了市场的增长,限制了其在医疗领域的潜在应用。

战略洞察

市场驱动力

慢性病发病率上升推动数字治疗市场增长

慢性病,包括心脏病、中风、糖尿病和肥胖症,占大多数任何国家的医疗保健费用。根据世界卫生组织(WHO)的报告,2020年全球有4.63亿成年人患有糖尿病,预计到2045年这一数字将增至6.29亿。亚太、欧洲、中东和非洲报告称,糖尿病患病率高。该疾病的主要特点是由于人体无法产生或有效利用激素胰岛素而导致血糖水平调节不充分,并且没有专门的治疗方法。根据国际糖尿病联盟发布的《2021 年 IDF 糖尿病地图集》,到 2021 年,北美报告约有 5100 万人患有糖尿病,预计到 2045 年这一数字将达到 6300 万。此外,东南亚的糖尿病患者人数约为 16.8%。全球糖尿病人口。到 2035 年,预计美国约有 1.3 亿成年人将患有某种形式的心血管疾病。

发达国家和发展中经济体的肥胖率正在迅速增加由于久坐和不健康的生活方式。根据经济合作组织(OECD)2017年公布的数据,OECD地区约19.5%的成年人口患有肥胖症。韩国和日本这一比例不到6%,匈牙利、新西兰、墨西哥和美国则超过30%。此外,过去十年中,澳大利亚、加拿大、智利、南非和英国的肥胖率迅速上升,约有 25% 或更多的成年人患有肥胖症。预计到 2030 年,美国、墨西哥和英国的肥胖水平将分别达到约 47%、约 39% 和约 35%。

按顺序为了加强慢性病管理并为患者提供更多治疗选择,数字疗法有助于提供基于证据的治疗解决方案。它使患者能够更好地控制他们的护理,并为糖尿病等慢性病管理提供潜在的解决方案。因此,慢性病患病率的上升正在推动数字治疗市场的发展。

 

细分分析

基于应用的见解

根据应用,数字治疗市场分为呼吸系统疾病、中枢神经系统疾病、戒烟、肌肉骨骼疾病、心血管疾病、糖尿病和其他应用。到 2021 年,糖尿病细分市场将占据最大的数字治疗市场份额,并且由于全球糖尿病发病率不断上升、发展中国家肥胖患病率较高,预计该细分市场在预测期内的复合年增长率最高。以及与肥胖相关疾病相关的重大风险和经济成本。

糖尿病是一种危及生命的慢性疾病,没有专门的治疗方法。它主要是由于人体无法产生或有效利用胰岛素激素引起的。这种能力阻碍了身体充分调节血糖水平。糖尿病有两种类型,即 I 型糖尿病(也称为尿崩症)和 II 型糖尿病(也称为糖尿病)。全球范围内,糖尿病的发病率和患病率正在稳步上升。 2 型糖尿病是最常见的糖尿病形式,并且随着文化和社会的变化而增加。在高收入国家,高达 91% 的成年人患有 2 型糖尿病。根据国际糖尿病联盟 (IDF) 2021 年地图集,全球约有 5.37 亿人患有糖尿病,预计到 2030 年这一数字将达到 6.43 亿。

分布基于渠道的洞察

就分销渠道而言,数字治疗市场分为患者、提供者、付款者和雇主。患者细分市场在 2021 年占据最大的数字治疗市场份额。然而,预计提供商细分市场在预测期内复合年增长率最高。

数字治疗市场,按应用程序 – 2021年和2028年

区域分析

北美在2021年占据数字治疗市场最大的市场份额,并预计在2021年保持其市场地位预测期。推动北美市场增长的因素包括降低医疗成本的需求不断增加、严格的医疗法规、医疗保健行业日益激烈的竞争以及快速的技术创新。此外,大型医疗保健企业的存在和数字治疗的日益增长正在推动该地区市场的扩张。在北美,美国的数字治疗市场份额最高。数字医疗在美国蓬勃发展,人口老龄化、慢性病患病率上升、监管变化以及向基于价值的医疗转变等多种因素正在支持数字医疗在日常生活中的日益渗透。

< h3> 

Propeller Health、Canary Health Inc.、NOOM INC.、2Morrow Inc、Teladoc Health、Welldoc Inc、FITBIT Inc、OMADA Health、Mango Health、Pear Therapeutics Inc 和 Happify Health 均在其中全球数字治疗市场增长的领先企业。对其他几个重要的市场参与者进行了分析,以全面了解市场及其生态系统。该报告提供了详细的市场洞察,帮助主要参与者制定市场增长战略。下面提到了一些进展:

  • 2021 年 11 月,Pear Therapeutics, Inc. 宣布已获得美国食品和药物管理局 (FDA) 的突破性器械认定)因其reSET-A PDT候选产品而设计,用于治疗酒精使用障碍(AUD)。 reSET-A 可能会扩大 Pear 的成瘾专营权,包括 FDA 授权的用于治疗物质使用障碍 (SUD) 和阿片类药物使用障碍 (OUD) 的产品。
  • 2020 年 9 月,Welldoc 宣布收到第九个其屡获殊荣的糖尿病平台 BlueStar 已获得美国食品和药物管理局 (FDA) 510(k) 批准。新的批准将胰岛素剂量支持范围扩大到大多数类型的胰岛素,包括用于 2 型糖尿病的推注和预混合胰岛素滴定。
  • 2021 年 5 月,Teladoc Health, Inc. 宣布推出 myStrength Complete,这是一款综合心理治疗仪健康服务通过单一、全面的体验为消费者提供个性化、有针对性的护理。
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which segment is dominating the digital therapeutics market?

The global digital therapeutics market, based on application, is segmented into diabetes, cardiovascular diseases, central nervous system (CNS) disease, respiratory diseases, smoking cessation, musculoskeletal diseases, and others. The diabetes segment held the largest share of the market in 2021 and the same segment registered the highest CAGR during the forecast period.

What are the driving factors for the digital therapeutics market across the country?

Factors such as the rising prevalence of chronic diseases and the growing need to reduce healthcare costs are driving the digital therapeutics market. However, cyber threats and risks related to data security are hampering the market growth.

What is the digital therapeutics market?

Digital therapeutics provide evidence-based therapeutic intrusions to patients that focus on the treatment of diseases with the programs by using the high-quality software. Digital therapeutics have made progress in the last few years, harnessing technology for the supplement or potentially replacing traditional clinical therapy. They are used independently or with devices and medications for the optimization of patient care and health outcomes.

Who are the major players in the digital therapeutics market?

The digital therapeutics market majorly consists of the players such as Propeller Health; Canary Health, Inc.; NOOM, INC.; 2Morrow, Inc.; Teladoc Health; Welldoc, Inc.; FITBIT, Inc.; OMADA Health; Mango Health; Pear Therapeutics, Inc.; and Happify Health.

The List of Companies - Digital Therapeutics Market

  1. Propeller Health
  2. Canary Health
  3. NOOM, INC.
  4. 2MORROW, INC.
  5. Teladoc Health
  6. Welldoc, Inc.
  7. FITBIT, INC.
  8. OMADA Health
  9. Mango Health
  10. Pear Therapeutics, Inc.
  11. HAPPIFY Health.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports